| Literature DB >> 27830328 |
Boukhemis Boukelia1, M C Fogarty2, R C R Davison3, G D Florida-James4.
Abstract
PURPOSE: The Clara cell protein CC16, secreted from Clara cells in the lung, is discussed as a potential biomarker for toxic effects on the airways. An increased concentration of CC16 in serum may be caused by increased permeability of the lungs. To investigate the changes in P-CC16 in response to an intense exercise bout performed at different times of day (9 am and 4 pm) of highly trained individuals.Entities:
Keywords: CC16; Diurnal variation; Immunological markers
Mesh:
Substances:
Year: 2016 PMID: 27830328 PMCID: PMC5306325 DOI: 10.1007/s00421-016-3489-5
Source DB: PubMed Journal: Eur J Appl Physiol ISSN: 1439-6319 Impact factor: 3.078
Mean RPE and mean running time diurnal variation
| 9 am | 4 pm | |
|---|---|---|
| Mean time | 32:59:51 ± 0:09 | 32:58:20 ± 0:10 |
| Mean speed | 17.6 ± 0.75 | 17.8 ± 0.61 |
* Diurnal difference was observed with the variables. Values are mean ± SD
Fig. 1The diurnal variation in mean HR (mean ± SD). *Significant diurnal variation at the identified time point
Fig. 2a Concentration of CC16 in plasma. b WBC, c neutrophil, and d lymphocyte concentration and circadian variation at 9 am and 4 pm (P < 0.05). *Significant diurnal variation at the identified time point. #Significant difference between identified timed trials
Lung function parameters in runners at pre-, post- and 1 h post-exercise at both times of the day: 9 am and 4 pm
| Pre-trial | Post-trial | 1 h post-trial | ||||
|---|---|---|---|---|---|---|
| 9 am | 4 pm | 9 am | 4 pm | 9 am | 4 pm | |
| FVC | 5.63 ± 0.91 | 5.59 ± 0.82 | 5.47 ± 0.88 | 5.31 ± 1.04 | 5.32 ± 0.88 | 5.77 ± 0.87 |
| FEV1 | 4.53 ± 0.90 | 4.46 ± 0.77 | 4.56 ± 0.89 | 4.39 ± 1.02 | 4.60 ± 1.02 | 4.70 ± 0.84 |
| FEV1R | 0.81 ± 0.11 | 0.80 ± 0.09 | 0.83 ± 0.13 | 0.83 ± 0.10 | 0.81 ± 0.10 | 0.81 ± 0.08 |
| PEF | 642 ± 166 | 647 ± 120 | 604 ± 139 | 640 ± 130 | 467 ± 262 | 649 ± 149 |
| FEF25–75 | 4.10 ± 1.84 | 4.17 ± 1.32 | 4.18 ± 1.75 | 4.48 ± 1.68 | 4.49 ± 1.89 | 4.54 ± 1.39 |
Forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), forced expiratory volume in 1 s ratio (FEV1R), forced expiratory flow (FEF) and forced expiratory flow 25–75% (FEF25–75) show no diurnal variation during the trials
Diurnal variation in total red blood cells (RBC), haemoglobin (HGB), haematocrit (HCT) and platelet (PLT), values are mean ± SD (109 l−1)
| Pre-trial | Post-trial | 1 h post-trial | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 9 am | 4 pm | %Δ | 9 am | 4 pm | %Δ | 9 am | 4 pm | %Δ | |
| RBC | 5.35 ± 0.39 | 4.87 ± 0.38 | 10 | 5.23 ± 0.49 | 5.04 ± 0.17 | 4 | 4.88 ± 0.27 | 4.92 ± 0.21 | <1 |
| HGB | 16.2 ± 1.25 | 14.8 ± 0.72 | 9 | 15.9 ± 1.64 | 15.4 ± 0.59 | 3 | 14.9 ± 0.74 | 15.0 ± 0.59 | <1 |
| HCT | 48.2 ± 3.51 | 44.0 ± 2.08 | 9 | 47.4 ± 4.91 | 45.7 ± 1.81 | 4 | 44.1 ± 1.89 | 44.5 ± 1.40 | <1 |
| PLT | 168 ± 12 | 216 ± 35 | 29 | 288 ± 44 | 275 ± 49 | 20 | 174 ± 24 | 229 ± 40 | 32 |
Values are mean ± SD